PepKon
Entity

  • PepKon

    Created in 2022


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    399 1,423

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Paris, France

    Paris

    France

  • Employees

    Scale: 2-10

    Estimated: 8

  • Engaged catalyst

    11
    0 0

  • Added in Motherbase

    1 year, 10 months ago
Description
  • Value proposition

    PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers.

    These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families

  • PepKon - first-in-class peptides in oncology, inspired by human biology

    Pepkon is a biotech company developing a therapeutic peptide platform in oncology. Its lead candidate is an agonist peptide targeting the TSP-1/CD47 pathway.

    • https://www.pepkon.fr/
Catalyst interactions
Catalyst TypeTweets Articles
Agoranov
Agoranov
Startup accelerator & VC, Technology, Information and Internet
Agoranov
Startup accelerator & VC, Technology, Information and Internet 		Other

13 Mar 2024


Social network dynamics
Similar entities
BETA
Last news
Show all articles